Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference

RICHMOND, Va., Dec. 6 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, announced today that it will present at the IBC 5th Annual Global Follow-On Biologics Conference on December 11, 2007 at 09:15 AM Eastern Time. The conferenc...

Insurance Department Releases Report on Executive Compensation at State's Largest Blues' Plans

... The compensation of the Highmark and ibc CEOs was commensurate with the rank of Highmark and ibc among Blue Cross and Blue Shield plans. For exampl...Frick was the ninth highest among Blue CEOs, while ibc was the eighth largest Blue. Highmark and...

Independence Blue Cross Harnesses Technology to Connect the Dots on Patient Care

...medical costs." To create Clinical Alerts, ibc leverages its database of claims information from ...r offices when prepping for upcoming appointments. ibc began sending alerts in April to physicians throug...ork for health plans. To date, more than 12,000 of ibc and its subsidiaries' network physicians received ...

Independence Blue Cross Expands Its Preventive Health Efforts With Focus on Heart Disease and Diabetes

...obesity, hypertension, high cholesterol, high blood pressure, and diabetes. ibc members who are identified with these symptoms are eligible for the program... medications. A recent member satisfaction survey showed that 88 percent of ibc members with a chronic condition, and 95 percent of non-chronic members, re...

Graduates Needing Health Insurance Have Cost-Effective Options

...rietors, early retirees, and other individuals not covered by a group plan. ibc recently developed a website to help individuals explore which health insur...member confidence and satisfaction. Later this year, insurers such as ibc will offer an option for group customers to extend dependent coverage so th...

Employee Health and Reducing Health Care Costs Focus of Working Wellness Expo June 17

...vely affect productivity and morale." Dr. Snyder will deliver opening remarks at the expo. To help employers drive down the cost of health care, ibc continues to offer customers its Wellness Partners(R) program - a worksite-based, targeted outreach program that helps employers to encourage healthie...

Healthcare Travel Congress 2009: Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism

...fine business strategies to maintain a competitive advantage in providing quality healthcare services," said Ms. Rebecca Wolfe, Divisional Director of ibc Asia - a company owned by the Informa Group. Dedicated to Asia's Healthcare "The Healthcare Travel Exhibition and Congress 2009 is a le...

TOPAZ Technologies Introduces Biosafety Software Solution

... Solution Automates ibc Protocol Operations and Addresses Medical Research...ty Committee (IBC). An end-to-end solution for the ibc protocol process, the Biosafety Solution compiles,...lude: the Protocols Module, created to streamline ibc protocol development and store critical research i...

As Biking Popularity Grows, so Must the Spotlight on Safety

...importance of safety and promote physical fitness, ibc offers each member of a family in its Healthy Life...ing a good safety example for your children." ibc encourages members purchasing bike helmets to be s...amily member per year. To obtain reimbursement, an ibc member simply mails or faxes a copy of the helmet ...

American Airlines Launches 2009 'Miles for the Cure' Campaign to Benefit Susan G. Komen for the Cure

...san G. Komen for the Cure's first Promise Grant, a study of inflammatory breast cancer (IBC) at The University of Texas M.D. Anderson Cancer Center. ibc is a very aggressive form of breast cancer. It is called inflammatory breast cancer because its main symptoms are swelling and redness of the breast, ...

IBC in Medical Technology

Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference

Interim Phase 1 Data Confirms Safety and Tolerability PLYMOUTH MEETING, Pa., Aug. 8 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR ) today announced interim data from the first Phase 1 clinical study of trodusquemine (MSI-1436) for the treatment of obesity. Anthony DelCo...

Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer

... we have built a pipeline of therapeutic product candidates that utilize several different mechanisms of action. We also have a majority ownership in ibc Pharmaceuticals, Inc., which is developing a novel Dock-and-Lock (DNL) methodology for making fusion proteins and multifunctional antibodies, and a ne...

Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data

...ary results will be presented by Vical's Vice President of Vaccine Research, Larry R. Smith, Ph.D., at 12:25 p.m. EDT today, Thursday, July 17, at the ibc Life Sciences Next Generation Vaccines conference (National Harbor, MD - July 17-18). In the Phase 1 trial, subjects were injected at Days 0 and 21....

New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens

...tive inflammatory breast cancer (IBC).(8) Although ibc is rare, it is the most aggressive form of primary...(9) This Phase II study of TYKERB monotherapy in ibc is the largest prospective clinical trial ever con...ients with HER2-positive (IHC 3+ or FISH positive) ibc that was refractory to anthracyclines, taxanes wer...

HUYA Bioscience Int'l Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China

..., and Eric Topol, one of top 10 cited biomedical researchers over past decade SAN FRANCISCO, March 3 /PRNewswire/ -- ibc Conference -- HUYA Bioscience International (HUYA), the leader in U.S./China pharmaceutical co-development, today announced the clinical advisory team...

HUYA Bioscience Int'l Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile

... Progress validates HUYA's innovative U.S./China pharmaceutical co-development model SAN FRANCISCO, March 3 /PRNewswire/ -- ibc Conference -- HUYA Bioscience International (HUYA), the leader in U.S./China pharmaceutical co-development, today announced the completion of three Ph...

Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia

...nited States, and more than 250 other issued patents worldwide, protects our product candidates and technologies. We also have a majority ownership in ibc Pharmaceuticals, Inc., which is developing a novel Dock and Lock (DNL) methodology, and a new method of delivering imaging and therapeutic agents sele...

Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases

...nited States, and more than 250 other issued patents worldwide, protects our product candidates and technologies. We also have a majority ownership in ibc Pharmaceuticals, Inc., which is developing a novel Dock and Lock (DNL) methodology, and a new method of delivering imaging and therapeutic agents sele...

Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy

...nited States, and more than 250 other issued patents worldwide, protects our product candidates and technologies. We also have a majority ownership in ibc Pharmaceuticals, Inc., which is developing a novel Dock and Lock (DNL) methodology, and a new method of delivering imaging and therapeutic agents sele...

Fractionated Radioimmunotherapy With (90)Y-epratuzumab in Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II Study

...nited States, and more than 250 other issued patents worldwide, protects our product candidates and technologies. We also have a majority ownership in ibc Pharmaceuticals, Inc., which is developing a novel Dock and Lock (DNL) methodology, and a new method of delivering imaging and therapeutic agents sele...

IBC in Biological News

A fisheye view of the deadliest breast cancer

...cts tumor cell survival. In all, the researchers were delighted with their breast cancer model’s ability to work as a real-time study window into ibc tumor behavior and as a rapid screening system for anticancer drugs. In the race against aggressive breast cancers, Stoletov and colleagues see their...

IBC in Biological Technology

VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress

SAN FRANCISCO, Aug. 1 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that Rebecca A. Taub, MD, VIA's senior vice president of research and develop...

BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery & Development of Innovative Therapeutics World Congress

SAN FRANCISCO, April 17 /PRNewswire/ -- BioSpace, the world's leading online bioscience job board community and life science career fair company, announced today an alliance with IBC Life Sciences whereby BioSpace will produce a Life Science Career Fair in conjunction with IBC's Drug Discovery...

Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice

...e fusion molecule ENB-0040 consisting of TSNALP, an immunoglobulin Fc domain, and an anionic peptide used to target the enzyme to bone at the upcoming ibc 2008 Bioprocessing International Conference, Sept. 23-26, 2008, in Anaheim, CA. About Hypophosphatasia Hypophosphatasia is a rare, inherited, and ...

IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts

... WESTBOROUGH, Mass., Aug. 4 /PRNewswire/ -- Today ibc Life Sciences kicks off the 13th Annual Drug Disco...l details visit http://www.drugdisc.com . About ibc Life Sciences ibc Life Sciences is the worldwide leader in scientifi...

Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC's Drug Discovery & Development of Innovative Therapeutics Conference

...email Keri Dostie at kdostie@ibcusa.com . About ibc Life Sciences ibc Life Sciences is the worldwide leader in scientifi...he life science industry. To develop its programs, ibc actively researches the advancements, technologies...

Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBC's 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress

...dhover WESTBOROUGH, Mass., May 7 /PRNewswire/ -- ibc Life Sciences announced the keynote line up for th...d Michael P. Keenan, Project Manager and Producer, ibc Life Sciences. "In addition, for the first time ev...email Keri Dostie at kdostie@ibcusa.com . About ibc Life Sciences ...

Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement

... Team of the Year. In 2005, he won the George B. Koelle Award for Scientific Excellence. In 2004, he was named Chief Scientific Officer of the Year by ibc Conferences. Dr. Dohlsten, 49, previously was Executive Vice President within Pharmaceutical Research & Development/Medicine at Boehringer Ingelheim...

EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference

...t Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Dr. John Drewe, Senior Director of Lead Discovery, will be presenting at the ibc conference on Assays and Cellular Targets at the Hotel Del Coronado in San Diego, CA on October 17, 2007. Dr. Drewe will describe the advances into pr...

IBC in Biological Dictionary

Antibody

...rm) Cell Function, YSK Antibody (C-term) Nuclear Signaling, ... This antibody is generated from rabbits immunized with a KLH conjugated ... The ibc Antibody ... Beyond Antibodies / Protein Engineering and Design September 21 - September 23 2009 ... of the Antibody Variable Gene Repertoire .....